The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 17, 2018

Filed:

Jun. 30, 2016
Applicant:

Medicinal Bioconvergence Research Center, Gyeonggi-do, KR;

Inventors:

Sunghoon Kim, Seoul, KR;

Yon-Sik Choi, Seoul, KR;

Hyunbo Shim, Seoul, KR;

Nam Ju Lee, Gyeonggi-do, KR;

Min Hwa Park, Seoul, KR;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/40 (2006.01); G01N 33/573 (2006.01); G01N 33/574 (2006.01); G01N 33/564 (2006.01);
U.S. Cl.
CPC ...
G01N 33/573 (2013.01); C07K 16/40 (2013.01); G01N 33/564 (2013.01); G01N 33/57488 (2013.01); C07K 2317/33 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/92 (2013.01);
Abstract

The present invention relates to an anti-lysyl-tRNA synthetase (KRS) antibody selectively binding to KRS, and a use thereof and, more specifically, to an antibody binding to human KRS or a fragment thereof, a method for producing the same, and a composition containing the same for diagnosing cancer, autoimmune diseases or inflammatory diseases. The antibody or fragment thereof of the present invention specifically binds to human KRS, and enables KRS detection and inhibition due to the absence of cross-linkage reactivity with the other proteins including the same ARS family, and thus the antibody or fragment thereof can be used to detect KRS and diagnose KRS-related diseases, i.e., cancer, autoimmune diseases or inflammatory diseases.


Find Patent Forward Citations

Loading…